| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/16/2002 | WO2002038142A2 Serotonergic compositions and methods for treatment of mild cognitive impairment |
| 05/16/2002 | WO2002038141A2 Compositions and methods for treatment of mild cognitive impairment |
| 05/16/2002 | WO2002038129A2 Delayed-release pharmaceutical formulations containing proinsulin c-peptide |
| 05/16/2002 | WO2002038108A2 Methods of treating disorders related to apoe |
| 05/16/2002 | WO2002038107A2 Stat modulators |
| 05/16/2002 | WO2002038106A2 Calcilytic compounds |
| 05/16/2002 | WO2002038105A2 Novel polyamine analog-amino acid conjugates useful as anticancer agents |
| 05/16/2002 | WO2002038035A2 Methods for inhibiting pain |
| 05/16/2002 | WO2002037968A1 Methods for treating disorders of neuronal deficiency with bone marrow-derived cells |
| 05/16/2002 | WO2002022658A3 Muteins of the cgrp 1-7 peptide fragment and use thereof as nicotinic neuronal receptor enhancers |
| 05/16/2002 | WO2002018448A3 Percarboxylated polysaccharides, and a process for their preparation |
| 05/16/2002 | WO2002018427A3 Nucleotide sequences which code for the cita gene |
| 05/16/2002 | WO2002012539A3 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis |
| 05/16/2002 | WO2002011717A9 Cosmetics to support skin metabolism |
| 05/16/2002 | WO2002011673A3 Methods of modulating activity of dxr |
| 05/16/2002 | WO2002004512A3 Purification of human troponin i |
| 05/16/2002 | WO2001098364A3 Peptides, compositions and methods for the treatment of burkholderia cepacia |
| 05/16/2002 | WO2001097851A3 Compositions and methods to improve the oral absorption of antimicrobial agents |
| 05/16/2002 | WO2001096395A3 Biosynthetic oncolytic molecules and uses therefor |
| 05/16/2002 | WO2001096372A3 Zinc transporters proteins and their use in medicinal preparations |
| 05/16/2002 | WO2001088105A3 Production of dendritic cells from bone-marrow stem cells |
| 05/16/2002 | WO2001088098A3 Fertilization of aged oocytes |
| 05/16/2002 | WO2001087335A3 Method for selectively inhibiting ghrelin action |
| 05/16/2002 | WO2001087333A3 Immune system stimulating means |
| 05/16/2002 | WO2001087270A3 Vaccine composition, method of preparing the same, and method of vaccinating vertebrates |
| 05/16/2002 | WO2001086003A8 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human lung |
| 05/16/2002 | WO2001085933A3 Plakoglobin interacting proteins |
| 05/16/2002 | WO2001085789A3 Extracellular domain of ryk protein for regulating angiogenesis |
| 05/16/2002 | WO2001083552A3 Human sez6 nucleic acids and polypeptides |
| 05/16/2002 | WO2001083547A3 Anti-inflammatory compounds and uses thereof |
| 05/16/2002 | WO2001081599A3 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors |
| 05/16/2002 | WO2001081405A3 Methods and compositions for the prevention and treatment of anemia |
| 05/16/2002 | WO2001081372A3 Vancomycin analogs |
| 05/16/2002 | WO2001081368A3 Blood-pressure reducing polypeptides containing vpp derived from microorganisms |
| 05/16/2002 | WO2001081366A3 Purification of ace inhibiting polypeptides containing vpp from milk |
| 05/16/2002 | WO2001079195A3 Pyridine and pyrazine derivatives as thrombin inhibitors |
| 05/16/2002 | WO2001077329A3 Human twik molecules and uses thereof |
| 05/16/2002 | WO2001077171A3 Soluble zalpha11 cytokine receptors |
| 05/16/2002 | WO2001076638A3 Compositions for drug delivery |
| 05/16/2002 | WO2001074857A3 Methods and compositions for modulating integrin-mediated cell-cell interactions |
| 05/16/2002 | WO2001074852A3 Protein having activity as an angiogenesis modulator |
| 05/16/2002 | WO2001073049A3 33877 and 47179, human glycosyl transferase family members and uses thereof |
| 05/16/2002 | WO2001070953A3 Identification of modulators of the inteferon gamma signaling pathway and their use in restenosis treatment |
| 05/16/2002 | WO2001069261A3 Proteins, genes and their use for diagnosis and treatment of vascular dementia |
| 05/16/2002 | WO2001068879A3 Human 1-aminocyclopropane-carboxylate synthase |
| 05/16/2002 | WO2001068678A3 Peptides that selectively bind to expanded polyglutamine repeat domains and methods of use thereof |
| 05/16/2002 | WO2001068144A3 Biodegradable immunomodulatory formulations and methods for use thereof |
| 05/16/2002 | WO2001066709A3 Sphingomyelinase enzymes and uses relating thereto |
| 05/16/2002 | WO2001058526A3 Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof |
| 05/16/2002 | WO2001055317A8 Nucleic acids, proteins, and antibodies |
| 05/16/2002 | WO2001048163A3 Dioxygenases catalyzing the asymetric cleavage of beta-carotene |
| 05/16/2002 | WO2001040521A3 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 05/16/2002 | WO2001034636A9 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/16/2002 | WO2001032885A9 Human lipase |
| 05/16/2002 | WO2001032128A9 Human chemokine beta-13 |
| 05/16/2002 | WO2001029235A3 Tms1 compositions and methods of use |
| 05/16/2002 | WO2001025408A9 Isolated dishevelled associated kinases, polynucleotides encoding the kinases, and methods of use thereof |
| 05/16/2002 | WO2001023428A3 Interleukin-2 receptor associated polypeptides |
| 05/16/2002 | US20020058804 Includes an active therapeutic agent joined to a blocking moiety sensitive to the catalytic action of molecules having retro- aldol and retro-Michael catalytic activity; antitumor; anticarcinogenic agents |
| 05/16/2002 | US20020058800 Compositions and methods for the diagnosis and treatment of immune disorders |
| 05/16/2002 | US20020058799 Novel pth |
| 05/16/2002 | US20020058798 Antibodies for use in the treatment of tumors |
| 05/16/2002 | US20020058797 Nef-attachable protein, DNA encoding the protein and a monoclonal antibody against said protein |
| 05/16/2002 | US20020058796 defl |
| 05/16/2002 | US20020058791 Hybrid cytokine of IL-7 and beta-chain of hepatocyte growth factor |
| 05/16/2002 | US20020058790 Nucleotide sequences coding protein for use in the detection, and screening of bactericides |
| 05/16/2002 | US20020058787 Mhc binding peptide oligomers and methods of use |
| 05/16/2002 | US20020058785 Novel lipopeptides as antibacterial agents |
| 05/16/2002 | US20020058783 Nucleotide sequences which code polypeptide for use as a wound healing agent; for preventing neuronal damage of stroke; for preventing skin aging |
| 05/16/2002 | US20020058685 Hydantoin derivative compounds, pharmace utical compositions, and methods of using same |
| 05/16/2002 | US20020058638 Decreasing blood glucose levels, inhibiting PEPCK expression, decreasing blood insulin levels, decreasing insulin resistance, increasing insulin sensitivity, decreasing blood triglyceride levels or decreasing blood cholesterol levels |
| 05/16/2002 | US20020058636 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 05/16/2002 | US20020058631 Dipeptide derivatives |
| 05/16/2002 | US20020058629 S-nitrosothiols as agents for the treatment of circulatory dysfunctions |
| 05/16/2002 | US20020058628 Antioxidants and intracellular glutathione raising agents for therapeutic treatments |
| 05/16/2002 | US20020058627 Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein |
| 05/16/2002 | US20020058626 Increasing blood platelet formation by administering a parathyroid hormone or a derivative |
| 05/16/2002 | US20020058625 Method for purifying factor vWF-complex by means of cation exchange chromatography |
| 05/16/2002 | US20020058624 Powder containing physiologically active peptide |
| 05/16/2002 | US20020058622 Water-insoluble or slightly water-soluble polyvalent metal salt (especially zinc) of a water soluble peptide type of physiologically active substance and a biodegradable polymer. |
| 05/16/2002 | US20020058621 Administering a milk-secretion stimulating amount of: i)an estrogen-like agent; ii) a progestational agent; and iii) a somatotropin; may include adjusting the photo-period to which the animal is exposed |
| 05/16/2002 | US20020058620 Cell growth regulation system |
| 05/16/2002 | US20020058619 Ligand for vascular endothelial growth factor receptor |
| 05/16/2002 | US20020058617 Effective for reducing body mass and for treating obesity-related diseases and disorderssuch as hyperlipidemias, atherosclerosis, diabetes, and hypertension. |
| 05/16/2002 | US20020058616 Coadministration of a an oral bioavailability-enhancing agent (e.g., a cyclosporin F or ketoconazole) with a drug that exhibits poor or inconsistent oral bioavailability (e.g., paclitaxel, docetaxel or etoposide) |
| 05/16/2002 | US20020058615 Endothelial specific targeting |
| 05/16/2002 | US20020058614 Especially administered by direct injection into the afflicted cartilagenous region or joint. |
| 05/16/2002 | US20020058613 Modulating the expression or bioactivity of a bcl family member in a neural cell such that axonal growth occurs. |
| 05/16/2002 | US20020058612 Methods of use of fibroblast growth factor, vascular endothelial growth factor and related proteins in the treatment of acute and chronic heart disease |
| 05/16/2002 | US20020058611 Therapeutic agent is conjugated to the carrier via a biodegradable disulfide bond. |
| 05/16/2002 | US20020058610 DNA (RNA) encoding such polypeptide and a procedure for producing such polypeptide by recombinant techniques; inhibiting such polypeptide for preventing and/or treating neoplasia; diagnostic assays |
| 05/16/2002 | US20020058608 Buffered drug formulations for transdermal electrotransport delivery |
| 05/16/2002 | US20020058607 Containing the amino acid sequence (G/S/A/E)-L-F-(F/I/L); each - is a peptide bond, each parenthesis encloses amino acids which are alternatives to one other, and each slash separating the alternative amino acids. |
| 05/16/2002 | US20020058336 Controlling cell binding; obtain target cell, incubate with substrate, monitor cell binding |
| 05/16/2002 | US20020058335 Compositions isolated from stromal cells and methods for their use |
| 05/16/2002 | US20020058323 Monkey urotensin II |
| 05/16/2002 | US20020058322 DNA molecules encoding fibrinolytically active polypeptide |
| 05/16/2002 | US20020058321 Method of determining the activity of 1-deoxy-D-xylulose-5-phosphate reductoisomerase and 1-deoxy-D-xylulose-5-phosphate synthase |
| 05/16/2002 | US20020058318 Gels for encapsulation of biological materials |
| 05/16/2002 | US20020058311 Genetically engineered dietetic protein for use in treatment of diabetes, atherosclerosis, hypertension and eating disorders |